ZT-1 for the Symptomatic Treatment of Mild to Moderate Alzheimer´s Disease: Preliminary Results of a Multicenter, Randomised, Double-blind Placebo and Active controlled Phase II Study

9th International Geneva Springfield Symposium on Advanced Alzheimer Therapy
April 19-22, 2006

J-M Orgogozo, E. Tamchès*, D. Wilkinson, S. Todorova Yancheva, C. Gagiano, P. Grosgurin*, H. Porchet*, P. Scalfaro*

*Debiopharm